Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela J Maxwell

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in CancerLaura M Campbell, Pamela J Maxwell, David J J Waugh
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Multi-faceted roles for CXC-chemokines in prostate cancer progressionDavid J J Waugh, Catherine Wilson, Angela Seaton, et al.
Anticancer Research|May 22, 2004
5-Fluorouracil: identification of novel downstream mediators of tumour responseJohn Boyer, Pamela J Maxwell, Daniel B Longley, et al.
Oncotarget|June 28, 2014
Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cellsPamela J Maxwell, Jessica Neisen, Johanna Messenger, et al.
Cancers|August 29, 2024
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment ResistanceShauna McClelland, Pamela J Maxwell, Cristina Branco, et al.
Seminars in Oncology|June 13, 2003
The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cellsDaniel B Longley, Tariq Latif, John Boyer, et al.
Plos One|May 17, 2012
Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancerCatherine Wilson, Pamela J Maxwell, Daniel B Longley, et al.
Carcinogenesis|May 20, 2008
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationAngela Seaton, Paula Scullin, Pamela J Maxwell, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosisCatherine Wilson, Colin Purcell, Angela Seaton, et al.
Cancer Research|August 9, 2003
Identification of 5-fluorouracil-inducible target genes using cDNA microarray profilingPamela J Maxwell, Daniel B Longley, Tariq Latif, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in CancerLaura M Campbell, Pamela J Maxwell, David J J Waugh
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Multi-faceted roles for CXC-chemokines in prostate cancer progressionDavid J J Waugh, Catherine Wilson, Angela Seaton, et al.
Anticancer Research|May 22, 2004
5-Fluorouracil: identification of novel downstream mediators of tumour responseJohn Boyer, Pamela J Maxwell, Daniel B Longley, et al.
Oncotarget|June 28, 2014
Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cellsPamela J Maxwell, Jessica Neisen, Johanna Messenger, et al.
Cancers|August 29, 2024
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment ResistanceShauna McClelland, Pamela J Maxwell, Cristina Branco, et al.
Seminars in Oncology|June 13, 2003
The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cellsDaniel B Longley, Tariq Latif, John Boyer, et al.
Plos One|May 17, 2012
Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancerCatherine Wilson, Pamela J Maxwell, Daniel B Longley, et al.
Carcinogenesis|May 20, 2008
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationAngela Seaton, Paula Scullin, Pamela J Maxwell, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosisCatherine Wilson, Colin Purcell, Angela Seaton, et al.
Cancer Research|August 9, 2003
Identification of 5-fluorouracil-inducible target genes using cDNA microarray profilingPamela J Maxwell, Daniel B Longley, Tariq Latif, et al.
Pageof 2